Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 5/20 | 0.34 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | CTSS | P25774 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL28308157 | 0.89 | LMNA (0.36) | — | |
| SCHEMBL667300 | 0.81 | KEAP1 (0.31) | — | |
| SCHEMBL43004 | 0.80 | HCAR2 (0.45) | DGAT1ALDH1A1 | |
| SCHEMBL43764 | 0.80 | HCAR2 (0.45) | DGAT1ALDH1A1 | |
| SCHEMBL375029 | 0.80 | HCAR2 (0.45) | DGAT1ALDH1A1 | |
| SCHEMBL11150713 | 0.79 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL28308158 | 0.79 | HCAR2 (0.31) | — | |
| SCHEMBL2970153 | 0.79 | CTSK (0.35) | CTSKDGAT1CTSS | |
| SCHEMBL27638180 | 0.78 | HCAR2 (0.43) | DGAT1 | |
| SCHEMBL4891444 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4717744-A1 | USE OF A COMPOSITION BASED ON CYANOACRYLATE AND (METH)ACRYLATE | Bostik SA (FR) | 2026-04-01 | — | — | EP | claimed |
| US-20250215132-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2025-07-03 | — | — | US | claimed |
| EP-4504844-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2025-02-12 | — | — | EP | claimed |
| US-20240240064-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2024-07-18 | — | — | US | claimed |
| EP-4334368-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2024-03-13 | — | — | EP | claimed |
| CN-117377706-A | Two-part curable composition | 博斯蒂克股份公司 | 2024-01-09 | — | — | CN | claimed |
| WO-2023194367-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2023-10-12 | — | — | WO | claimed |
| EP-4257648-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2023-10-11 | — | — | EP | claimed |
| WO-2022234017-A1 | TWO-PART CURABLE COMPOSITION | BOSTIK SA (FR) | 2022-11-10 | — | — | WO | claimed |
| EP-4086294-A1 | TWO-PART CURABLE COMPOSITION | Bostik SA (FR) | 2022-11-09 | — | — | EP | claimed |
| EP-1100380-B1 | BIOABSORBABLE BLENDS AND SURGICAL ARTICLES THEREFROM | TYCO HEALTHCARE (US) | 2011-11-02 | — | — | EP | claimed |
| EP-1100380-A4 | BIOABSORBABLE BLENDS AND SURGICAL ARTICLES THEREFROM | TYCO HEALTHCARE (US) | 2008-07-30 | — | — | EP | claimed |
| US-20040013614-A1 | Acrylic-based adhesive composition | BTG INTERNATIONAL LIMITED (GB) | 2004-01-22 | — | — | US | claimed |
| EP-1341563-A1 | ACRYLIC-BASED ADHESIVE COMPOSITION | UNIVERSIDAD DE ALICANTE (ES) | 2003-09-10 | — | — | EP | claimed |
| WO-2002009784-A1 | ACRYLIC-BASED ADHESIVE COMPOSITION | UNIVERSIDAD DE ALICANTE (ES) | 2002-02-07 | — | — | WO | claimed |
| EP-1100380-A1 | BIOABSORBABLE BLENDS AND SURGICAL ARTICLES THEREFROM | TYCO HEALTHCARE GROUP LP (US) | 2001-05-23 | — | — | EP | claimed |
| WO-2000072761-A1 | BIOABSORBABLE BLENDS AND SURGICAL ARTICLES THEREFROM | TYCO HEALTH CARE GROUP, LP (US) | 2000-12-07 | — | — | WO | claimed |
| EP-4717744-A1 | USE OF A COMPOSITION BASED ON CYANOACRYLATE AND (METH)ACRYLATE | Bostik SA (FR) | 2026-04-01 | — | — | EP | disclosed |
| US-6183593-B1 | CURABLE BLEND | CLOSURE MEDICAL CORPORATION | 2001-02-06 | — | — | US | disclosed |
| WO-2000072761-A1 | BIOABSORBABLE BLENDS AND SURGICAL ARTICLES THEREFROM | TYCO HEALTH CARE GROUP, LP (US) | 2000-12-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040013614-A1 | Acrylic-based adhesive composition | C5AR1, C1R, COL2A1 | CTSK 3924/4885DGAT1 2764/4885CTSS 4176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.